advanced tumors

People with advanced tumors are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are a male or female with primary ITP with duration of >6 months in ages 12 to <18 years • Have histologically or cytologically documented, locally-advanced or metastatic solid malignancy of any type • Have adequate hematologic, hepatic, and renal function You may NOT participate in this study if you: • Have history (within 5 years of Study Day 1) or current, active malignancy requiring or likely to require chemotherapeutic or surgical treatment during the study, with the exception of non-melanoma skin cancer • Have had transfusion with blood, blood products, plasmapheresis, or use of any other rescue Medications • Have had treatment with rituximab or splenectomy within the 3 months • Have a history of solid organ transplant • Have known immunodeficiency virus (HIV) infection. Hepatitis B, or C • Have a positive COVID-19 molecular test • Have COVID-19 vaccine within 14 days • Are pregnant or breastfeeding Contact Information Melissa Suchanek, Study Coordinator 111 E. 210th Street Bronx, NY 10467 Phone: (718) 798-5687 Email: Melissa.Sachanek@EINSTEINMED.ORG 21-06-316